Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesBiologics : Target - specific treatment of systemic and cutaneous autoimmune diseases
Indian Journal of Dermatology, 07/10/09
Raychaudhuri SP et al. - Biologics are becoming important in the treatment of systemic and cutaneous autoimmune diseases. They are designed to target specific components of immune system. The development of TNF-alpha blockers in the treatment of psoriasis, psoriatic arthritis, rheumatoid arthritis, Crohn's disease and ankylosing spondylitis have been major breakthroughs. Likewise, B-cell depletion has proved to be equally revolutionary for the treatment of lupus, pemphigus, certain vasculitides etc.
Related Articles
Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: An analysis using a large observational data bank
Clinical Therapeutics, 10/16/09
Relevance Score: 89%
Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs
Journal of Rheumatology, 10/05/09
Relevance Score: 89%
ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature
Arthritis Research & Therapy, 11/17/09
Relevance Score: 87%
Targeting Sarcomas: Novel Biological Agents and Future Perspectives
Current Drug Targets, 10/23/09
Relevance Score: 87%
Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 87%
Today in Autoimmune/Bullous Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Hyper IgE syndrome with umbilical hernia
Indian Journal of Dermatology, 11/25/09
Pemphigus vegetans in a patient with colonic cancer
Indian Journal of Dermatology, Venereology and Leprology , 11/19/09
The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites
Journal of the European Academy of Dermatology and Venereology, 11/16/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pulsed High-Dose Corticosteroids Combined With Low-Dose Methotrexate Treatment in Patients With Refractory Generalized Extragenital Lichen Sclerosus
Archives of Dermatology, 11/25/09
Failure of omalizumab in cholinergic urticaria
Clinical and Experimental Dermatology, 11/25/09
Disappearance of Lentigines in a Patient Receiving Imatinib Treatment for Familial Gastrointestinal Stromal Tumor Syndrome
Archives of Dermatology, 11/25/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis
International Journal of Dermatology, 11/25/09
Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life
Clinical and Experimental Dermatology, 11/25/09
Urinary biomarker of oxidative stress in patients with psoriasis vulgaris and atopic dermatitis
Journal of the European Academy of Dermatology and Venereology, 11/24/09
Sponsor
Article Search
Sponsor